RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
T2 Biosystems Stock

T2 Biosystems Market capitalization 2024

T2 Biosystems Market capitalization

887,915.2 USD

Ticker

TTOO

ISIN

US89853L1044

WKN

A119H3

In 2024, T2 Biosystems's market cap stood at 887,915.2 USD, a -94.04% increase from the 14.91 M USD market cap in the previous year.

The T2 Biosystems Market capitalization history

YEARMarket Capitalization (undefined USD)
2023107.36
202255.48
2021190.17
2020109.98
2019114.86
2018303.83
2017218.17
2016382.05
2015-
2014-
2013-
2012-

T2 Biosystems Aktienanalyse

What does T2 Biosystems do?

T2 Biosystems Inc. is an American company that was founded in 2006. The company is based in Lexington, Massachusetts. The founders of T2 Biosystems aimed to create an innovative diagnostic system that could improve hospital performance. Their business model is based on the development, manufacturing, and distribution of innovative instruments and diagnostic solutions. T2 Biosystems operates in various sectors, with a focus on diagnosis and healthcare solutions. The key areas are: 1. Infectious diseases: T2 Biosystems develops systems that enable rapid and accurate diagnosis of infectious diseases in hospitals and other medical facilities. The team has already made significant progress in detecting infections such as sepsis, pneumonia, and other diseases that require prompt diagnosis to increase patient survival rates. 2. Hematology: The company has also developed a product called T2HemoStat, which improves accuracy in determining biomarkers in blood samples. HemoStat allows for real-time analysis of patient samples to achieve faster results than current standard tests. 3. Healthcare: T2 Biosystems also offers solutions to improve healthcare. The goal is to address issues in healthcare by using data and information more intelligently. The company is working on products tailored to the needs of hospitals and healthcare providers. T2 Biosystems pursues a collaborative strategy, fostering cooperation among clinics, customers, and companies. T2 Biosystems has successfully launched several products, including the T2Dx instrument, which enables rapid and accurate detection of infections. The measurement system is based on T2 Magnetic Resonance (T2MR) technology, which can identify cells and biomolecules based on magnetic resonance. The T2Dx system is also capable of identifying drugs directly in the tests, allowing for better utilization of antibiotics to combat resistant bacteria. In collaboration with Harvard Medical School, the company is also working on developing specific tests focused on the detection of bacteria or viruses. The team at T2 Biosystems has developed an innovative system that allows for the analysis of bacterial or viral strains. T2 Biosystems has a rapidly growing customer base and is a key player in the healthcare market. The company has already established important partnerships with some of the leading hospitals in the US and continues to work on forming further partnerships in other parts of the world. The products of T2 Biosystems have received numerous awards, including the "Best of Show" prize at the Association of Clinical Chemistry Annual Meeting and the "Medical Device Excellence Award" from the Massachusetts Medical Device Industry Council. The company operates in a highly competitive market. To remain competitive, T2 Biosystems heavily invests in research and development. The company also has a strong presence on social media to raise awareness of their products and services. T2 Biosystems aims to achieve further medical advancements and develop innovative technologies to improve patient care in the future. T2 Biosystems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring T2 Biosystems's Market Capitalization

T2 Biosystems's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of T2 Biosystems's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

T2 Biosystems's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in T2 Biosystems’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about T2 Biosystems stock

What is the current T2 Biosystems market capitalization?

The current market capitalization of T2 Biosystems is 887,915.2 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like T2 Biosystems.

How has the market capitalization of T2 Biosystems developed in recent years?

The market capitalization of T2 Biosystems has increased/decreased by -94.04% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of T2 Biosystems?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of T2 Biosystems?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of T2 Biosystems have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does T2 Biosystems pay?

Over the past 12 months, T2 Biosystems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, T2 Biosystems is expected to pay a dividend of 0 USD.

What is the dividend yield of T2 Biosystems?

The current dividend yield of T2 Biosystems is .

When does T2 Biosystems pay dividends?

T2 Biosystems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of T2 Biosystems?

T2 Biosystems paid dividends every year for the past 0 years.

What is the dividend of T2 Biosystems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is T2 Biosystems located?

T2 Biosystems is assigned to the 'Health' sector.

Wann musste ich die Aktien von T2 Biosystems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of T2 Biosystems from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did T2 Biosystems pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of T2 Biosystems in the year 2023?

In the year 2023, T2 Biosystems distributed 0 USD as dividends.

In which currency does T2 Biosystems pay out the dividend?

The dividends of T2 Biosystems are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von T2 Biosystems

Our stock analysis for T2 Biosystems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of T2 Biosystems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.